Entolimod, an Adjuvant for Vaccine Augmentation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The primary objective of this pilot study to evaluate the safety of low dose Entolimod in normal, healthy, non-patient normals. This clinical trial in 40 normal humans compares a single dose of 4 ug Td (2 ug of TT and 2 ug of diphtheria toxoid + 3000 ug of alum with or without entolimod. Subjects will be randomized to: Td alone (n=15) and Td+ entolimod (n=25). The investigators expect that Td + entolimod will double the anti-TT and anti-diphtheria AB levels over Td alone.
Epistemonikos ID: 63faed0a8d6eedf3f95fd21e8e351dd4124f520f
First added on: May 20, 2024